Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » A1c

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Why Self-Monitoring of Blood Sugars Is Critical in All Patients with Diabetes Posted: Friday, October 22, 2010

Vigilant monitoring of glycemic levels is the key to success for comprehensive glycemic control in patients with Type 2 diabetes.

Kidney Function in Patients with Diabetic Nephropathy Linked to Seasonal BP Posted: Sunday, October 10, 2010

Researchers say clinicians should consider seasonal variations in systolic blood pressure when treating patients with diabetic nephropathy, after finding seasonal variations in urinary albumin-to-creatinine ratio (UACR), likely linked to blood-pressure changes.

EASD: Pioglitazone-Sitagliptin Combination Achieves Durable Glycemic Control Posted: Sunday, October 03, 2010

Adding 50 mg of sitagliptin (Januvia) to pioglitazone (Actos) allowed patients with Type 2 diabetes to achieve sustained glycemic control, a yearlong trial showed.

EASD: New Drug Classes Entering Type 2 Pipeline Posted: Sunday, October 03, 2010

Farnesoid X receptor agonists, 11-â-HSD1 inhibitors, and glucokinase activators are some of the new approaches to treating Type 2 diabetes described in research presented, but some senior researchers expressed doubts about the clinical need for them.

EASD: Once-Weekly Exenatide Benefit Sustained over 52 Weeks Posted: Sunday, October 03, 2010

Once-Weekly Exenatide maintains a drop in A1c of 2 points for more than 52 weeks.

EASD: Moderate Wine Drinking Lowers Fasting Glucose in Type 2 Diabetes Posted: Sunday, October 03, 2010

A glass of merlot or perhaps sauvignon blanc with dinner may offer modest benefits for patients with Type 2 diabetes, said researchers.

EASD: Adding Incretin to Insulin Lowers HbA1c Posted: Sunday, October 03, 2010

Adding exenatide to insulin glargine for patients who aren't fully controlled with insulin glargine and/or other oral agents can help to improve their blood glucose.

New First in Class Type 2 Diabetes Drug Cycloset® Launches November Posted: Tuesday, September 21, 2010

VeroScience announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize Cycloset®, which has been approved by the FDA as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes both as mono-therapy and in combination with other oral antidiabetic agents.

Why Fish Oils Can Improve Diabetes Control Posted: Tuesday, September 14, 2010

Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance.

A1c Test for Diagnosis Not Perfect: Study Posted: Tuesday, September 14, 2010

The limited sensitivity of the A1C test may result in missed or delayed diagnosis of Type 2 diabetes, whereas the use of current OGTT criteria will fail to identify a high proportion of individuals with A1C >6.5%. Further studies and discussion are needed before revising guidelines for Type 2 diabetes diagnosis.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.